CARRIERI, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 8.653
AS - Asia 2.788
EU - Europa 2.548
SA - Sud America 666
AF - Africa 83
OC - Oceania 5
Totale 14.743
Nazione #
US - Stati Uniti d'America 8.567
SG - Singapore 1.175
CN - Cina 701
BR - Brasile 593
DE - Germania 522
SE - Svezia 403
IT - Italia 377
HK - Hong Kong 364
RU - Federazione Russa 335
VN - Vietnam 242
GB - Regno Unito 206
UA - Ucraina 166
FR - Francia 160
FI - Finlandia 120
IN - India 75
ID - Indonesia 43
CA - Canada 38
IE - Irlanda 38
CI - Costa d'Avorio 33
NL - Olanda 33
BE - Belgio 32
BD - Bangladesh 30
TR - Turchia 30
MX - Messico 29
AR - Argentina 26
JP - Giappone 26
AT - Austria 25
PL - Polonia 25
IR - Iran 22
ES - Italia 18
CH - Svizzera 17
CZ - Repubblica Ceca 16
IQ - Iraq 14
ZA - Sudafrica 14
LT - Lituania 13
EC - Ecuador 12
PK - Pakistan 11
KE - Kenya 9
CO - Colombia 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
CL - Cile 7
JM - Giamaica 7
EE - Estonia 6
KR - Corea 6
VE - Venezuela 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
AU - Australia 4
BY - Bielorussia 4
EG - Egitto 4
JO - Giordania 4
NG - Nigeria 4
NO - Norvegia 4
PY - Paraguay 4
RO - Romania 4
TH - Thailandia 4
UY - Uruguay 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
DK - Danimarca 3
GA - Gabon 3
IL - Israele 3
MA - Marocco 3
PE - Perù 3
TN - Tunisia 3
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
GE - Georgia 2
HR - Croazia 2
IS - Islanda 2
LB - Libano 2
MY - Malesia 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AN - Antille olandesi 1
BH - Bahrain 1
CR - Costa Rica 1
CV - Capo Verde 1
ET - Etiopia 1
GI - Gibilterra 1
GN - Guinea 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MW - Malawi 1
NI - Nicaragua 1
Totale 14.736
Città #
Dallas 2.452
Fairfield 725
Ashburn 588
Singapore 580
Woodbridge 506
Chandler 505
Houston 392
Jacksonville 354
Hong Kong 353
Nyköping 298
Seattle 286
Cambridge 251
Wilmington 239
Ann Arbor 222
Beijing 174
Bari 135
Nanjing 113
Lawrence 107
Roxbury 107
Marseille 97
Los Angeles 93
New York 86
Dong Ket 84
Boardman 70
Des Moines 64
Ho Chi Minh City 62
Brooklyn 60
Munich 59
Princeton 58
Santa Clara 45
São Paulo 45
Hanoi 43
London 41
San Diego 39
Dublin 36
Council Bluffs 34
Jakarta 34
Abidjan 33
Buffalo 33
Jiaxing 32
Brussels 31
Inglewood 31
North Bergen 30
Nanchang 29
Milan 26
Moscow 25
Amsterdam 24
Chicago 23
Helsinki 23
Frankfurt am Main 22
Shenyang 22
Tokyo 22
Nuremberg 20
Warsaw 20
Rio de Janeiro 19
Tianjin 19
Redwood City 18
Dearborn 16
Guangzhou 16
San Francisco 16
West Jordan 16
Changsha 15
Chennai 15
Denver 15
Hebei 15
Belo Horizonte 13
Mumbai 13
Paris 13
Sannicandro di Bari 13
Kansas City 12
Atlanta 11
Brasília 11
Leawood 11
Shanghai 11
Toronto 11
Boston 10
Mexico City 10
Redondo Beach 10
Ankara 9
Boydton 9
Curitiba 9
Düsseldorf 9
Falkenstein 9
Falls Church 9
Istanbul 9
Montreal 9
Phoenix 9
Rome 9
The Dalles 9
Wuhan 9
Brno 8
Goiânia 8
Johannesburg 8
Juiz de Fora 8
Long Beach 8
San Mateo 8
Stockholm 8
Columbus 7
Fragagnano 7
Grafing 7
Totale 10.397
Nome #
1, 3‐Benzothiazoles as Antimicrobial Agents 1.083
1,3-Benzothiazoles as Antimicrobial Agents 1.067
1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1 1.057
4H-1,4-benzothiazine, dihydro-1,4-benzothiazinones and 2-amino-5- fluorobenzenethiol derivatives: Design, synthesis and in vitro antimicrobial screening 191
Probiotic and Tea Tree Oil Treatments Improve Therapy of Vaginal Candidiasis: A Preliminary Clinical Study 188
miRNAs for the Detection of MultiDrug Resistance: Overview and Perspectives 185
Chasing ChEs-MAO B Multi-Targeting 4-Aminomethyl-7-Benzyloxy-2H-Chromen-2-ones 177
2-Aminobenzothiazole derivatives: Search for new antifungal agents 176
A convenient synthesis of lubeluzole and its enantiomer: Evaluation as chemosensitizing agents on human ovarian adenocarcinoma and lung carcinoma cells 161
Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease 160
Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists 157
Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects 146
Structure-property relationship study of the HPLC enantio-selective retention of neuroprotective 7-[(1-alkylpiperidin-3-yl)methoxy]coumarin derivatives on an amylose-based chiral stationary phase 146
The chemosensitizing agent lubeluzole binds calmodulin and inhibits Ca2+/calmodulin-dependent Kinase II 146
2-(2-Phenylcyclopropyl)-Imidazolines: Reversed Enantioselective Interaction At I1 and I2 Imidazoline Receptors 140
,3-Benzothiazoles as Antimicrobial Agents 139
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors 136
Effect of Methyl -β- Cyclodextrin on the antimicrobial activity of a new series of poorly water-soluble benzothiazoles 135
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp 133
New tetrahydroisoquinoline-based P-glycoprotein modulators: Decoration of the biphenyl core gives selective ligands 132
Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein 130
Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use-Dependent Inhibitors of Voltage-Gated Sodium Channels 129
Synthesis.and biological evaluation of pyridazino[4,3-b]indoles and indeno[1,2-c]pyridazines as new ligands of central and peripheral benzodiazepine receptors 128
Repositioning of Endonuclear Receptors Binders as Potential Antibacterial and Antifungal Agents. Eptyloxìm: A Potential and Novel Gyrase B and Cytochrome Cyp51 Inhibitor 127
Ligands of neuronal nicotinic acetylcholine receptor (nAChR): inferences from the Hansch and 3-D Quantitative Structure-Activity Relationship (QSAR) models 125
Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships 124
High Affinity Central Benzodiazepine Receptor Ligands. Part 2: Quantitative Structure-Activity Relationships and Comparative Molecular Field Analysis of Pyrazolo[4,3-c]quinolin-3-ones 123
Alpidem analogues containinig a GABA or glycine moiety as new anticonvulsant agents 118
1,3,5-triazine derivatives as dual inhibitors of 5-HT6R/FAAH in search of new therapy for Alzheimer's disease 117
3D-QSAR models and docking studies of reversible inhibitors of type A and B Monoamine Oxidases 114
Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysis 114
Structural Determinants in the Binding of BB2 Receptor Ligands: In Silico, X-Ray and NMR Studies in PD176252 Analogues. 114
Investigation on platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids 111
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 111
Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models. 110
Elucidation of the synergistic action of Mentha Piperita essential oil with common antimicrobials 110
Guinea-pig ileum as ex vivo model useful to characterize ligands displaying Imidazoline I2 and Adrenergic alpha2 mixed activity: a preliminary study 108
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents 108
The in silico insights of α-adrenergic receptors over the last decade: methodological approaches and structural features of the 3D models 106
MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY: CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 104
Understanding of the MAO-A and B Reversible Inhibitory Activity and Selectivity by Using 3D Descriptors of Lipophilicity 101
Binding Models of Reversible Inhibitors to Monoamine Oxidases 101
Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist 99
(contributo in convegno) MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY; CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 99
Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor alpha/gamma ligand LT175 98
Enhanced solubility and antibacterial activity of lipophilic fluoro-substituted N-benzoyl-2-aminobenzothiazoles by complexation with beta-cyclodextrins 98
2-D and 3-D modeling of imadazoline receptor ligands: insights into pharmacophore 97
High affinity central benzodiazepine receptor ligands: synthesis and structure-activity relationship studies of a new series of pyrazolo[4,3-c]quinolin-3-ones. 96
alpha2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(Biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole 96
Allyphenyline Analogues Potentially Useful in the Management of Chronic Pain and Opioid Addiction 95
Evaluation of water‐soluble Mannich base prodrugs of 2,3,4,5‐tetrahydroazepino[4,3‐b]indol‐1(6H)‐one as multitarget‐directed agents for Alzheimer’s disease 95
Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies. 94
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE) 94
Papain catalyzed hydrolysis of aryl esters: a comparison of the Hansch, Docking and CoMFA methods 93
Neuronal Nicotinic Agonists: a Multi-approach Development of the Pharmacophore 93
Lubeluzole: from anti-ischemic to chemosensitizing agent 93
Might the observed a2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 92
Rational design of the new antihypertensive I1-receptor ligand 2-(2-biphenyl-2-yl-1-methyl-ethyl-)4,5-dihydro-1H-imidazole 89
Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists 89
Analisi conduttimetrica 89
High affinity central benzodiazepine receptor ligands II: QSAR studies and CoMFA analysis pyrazolo(4,3-c)quinolin-3-ones 86
Diffuse Intrinsic Pontine Glioma (DIPG): breakthrough and clinical perspective 84
Neuronal nicotinic receptor agonists: multi-approach pharmacophore development and 3D-QSAR predictive models, 83
Binding models of reversible inhibitors to type-B monoamine oxidase 83
Pharmacophore development and 3D-QSAR study of I1 imidazoline binding site ligands 80
alfa2-adrenoreceptors profile modulation. 2.1 Biphenyline analogues as tools for selective activation of alfa2C-subtype 79
Sintesi alternativa del lubeluzolo e del suo enantiomero e valutazione come agenti in grado di potenziare l'effetto di farmaci antitumorali. 79
Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics. 78
Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors alpha/gamma agonists 77
A twenty-year journey exploring coumarin-based derivatives as bioactive molecules 75
Neuronal nicotinic receptor agonists: multi-approach pharmacophore development and 3D QSAR predictive models 75
2D- and 3D-QSAR of tocainide and mexiletine analogues acting as Na(v)1.4 channel blockers 75
Recent Trends And Future Prospects In Computational GPCR Drug Discovery: From Virtual Screening To Polypharmacology. 73
Linezolid hybrid analogs: synthesis and antimicrobial studies of oxalodinone-mercaptobenzothiazole compounds 72
New molecular requirements of Toc derivatives bearing a novel class of Nav1.4 blockers 71
Binding of tracizolines to the imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models 71
Dimeric analogs of the dual PPARα/γ agonist LT-175: design, synthesis and biological evaluation. 70
null 70
Scouting around 1,2,3,4-Tetrahydrochromeno[3,2-c]pyridin-10-ones for Single- and Multitarget Ligands Directed towards Relevant Alzheimer's Targets 70
Comparative Molecular Field Analysis of pyridawinone-containing alfa1-antagonists 68
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease 68
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates 68
null 66
SAR of Non-Nucleoside HIV-1 RT inhibitors (NNRTIs): Comparative Molecular field Analysis (CoMFA) and Docking Studies 65
null 65
Modeling the structural basis of the human CCR5 chemokine receptor functions: from homology model-builiding and molecular dynamics validation to agonist and anatgonist docking 64
Multi-approach development of a new pharmacophore for neuronal nicotinic acetylcholine receptor agonists, 64
Antifungal Biofilm Inhibitory Effects of Combinations of Diclofenac and Essential Oils 64
Novel Phenothiazine/Donepezil-Like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease 63
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases 63
Synthesis and Antimicrobial Activity of new-substitud-4H-1,4-benzothiazines 63
Antibiofilm Effects of Plant Extracts Against Staphylococcus aureus 62
stant collaboration in drug discovery: The LINK3D project 62
Enantiomeric Separation and Molecular Modelling of Bioactive 4-Aryl-3,4-dihydropyrimidin-2(1H)-one Ester Derivatives on Teicoplanin-Based Chiral Stationary Phase 61
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders 61
Theoretical evidence of a salt bridge disruption as the initiating process for the alpha1d-adrenergic receptor activation: a molecular dynamics and docking study 59
Non-Antibiotic Drug Repositioning as an Alternative Antimicrobial Approach 58
Benzothiazole-Phthalimide Hybrids as Anti-Breast Cancer and Antimicrobial Agents 58
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW ANALOGS OF THE DUAL PPARα/γ AGONIST LT175. 58
Extended form of a retro-inverso peptide stabilized by beta-sheet unidirectional H-bonds: Crystallographic and NMR evidence 57
Totale 12.855
Categoria #
all - tutte 55.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021783 0 0 0 0 0 61 103 70 111 180 105 153
2021/2022851 43 105 11 41 22 48 49 44 56 84 134 214
2022/20231.556 220 141 93 125 183 190 14 155 337 22 40 36
2023/2024675 44 99 26 43 52 102 40 29 39 54 52 95
2024/20252.436 73 69 196 109 66 165 221 233 148 145 356 655
2025/20264.954 698 773 2.169 677 565 72 0 0 0 0 0 0
Totale 15.125